Amount raised
$5.3M
Round
Pre-Seed
Date raised
November 10, 2026
Founded
—
Founders
- Samuel MyllykangasCo-founder and CEO
- Jason BuenrostroCo-founder
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Switchpoint Bio
They provide a blood-based epigenomic platform for drug developers to understand how disease and treatment affect human biology.
- How much did Switchpoint Bio raise?
- Switchpoint Bio raised $5.3M in a Pre-Seed round on November 10, 2026.
- Who founded Switchpoint Bio?
- Samuel Myllykangas and Jason Buenrostro co-founded Switchpoint Bio.